Valuation : Shivalik Rasayan Limited

Market Cap 505.51Cr 5.33Cr 4.58Cr 4.31Cr 3.94Cr 7.35Cr 7.38Cr 51Cr 20Cr 258.38Cr 20Cr 20Cr 822.22Cr P/E 2025
59.1x
P/E 2026 28.2x
Enterprise Value 593.93Cr 6.26Cr 5.39Cr 5.07Cr 4.62Cr 8.63Cr 8.67Cr 60Cr 23Cr 303.57Cr 24Cr 23Cr 966.04Cr EV / Sales 2025
3.4x
EV / Sales 2026 1.21x
Free-Float
41.9%
Yield 2025
0.08%
Yield 2026 0.23%
14/08 Shivalik Rasayan Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
23/07 Shivalik Rasayan Limited announced that it expects to receive INR 152.25 million in funding from Bishnoi Exports Private Limited, Growel Remedies Limited, Kim Ginnerup ApS and other investors CI
27/05 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
27/05 Shivalik Rasayan Limited Announces Resignation of Sanjay Bansal as Non-Executive Director, Effective May 27, 2026 CI
27/05 Shivalik Rasayan Limited Recommends Final Dividend for the Financial Year 2025-26, Payable on or After October 15, 2026 CI
27/05 Shivalik Rasayan Ltd March-quarter consol net profit 45.3 million rupees RE
13/02 Shivalik Rasayan Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
14/11 Shivalik Rasayan Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
29/25/29 Shivalik Rasayan Limited Approves the Re-Designation of Mr. Ashwani Kumar Sharma as a Non-Executive, Non-Independent Director CI
12/25/12 Shivalik Rasayan Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
30/25/30 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
30/25/30 Shivalik Rasayan Limited announces Annual dividend, payable on October 27, 2025 CI
24/25/24 Medicamen Biotech Limited announced that it has received INR 535.6816 million in funding from Kim Ginnerup ApS, Shivalik Rasayan Limited, VERALOGIX HOLDINGS LTD and other investors CI
1 day+1.82%
1 week-2.12%
Current month-2.12%
1 month+26.41%
3 months+37.51%
6 months+16.50%
Current year-9.81%
1 week 310
Extreme 310
343.95
1 month 240.65
Extreme 240.65
343.95
Current year 206
Extreme 206
371.3
1 year 206
Extreme 206
495.4
3 years 206
Extreme 206
873.6
5 years 206
Extreme 206
1,196.8
10 years 62.04
Extreme 62.04
1,196.8
Manager TitleAgeSince
Chief Executive Officer 64 17/11/2018
Director of Finance/CFO - 01/11/2001
Chief Tech/Sci/R&D Officer - 11/01/2024
Director TitleAgeSince
Director/Board Member 64 17/11/2018
Chairman 62 23/02/2002
Director/Board Member 67 18/07/2003
Date Insider Type Main position Quantity % Market Cap. Importance
01/07/24 Don 21,500 0.1382%
26/06/24 Sell 1,08,500 0.6973%
Change 5-day change 1-year change 3-year change Capi.($)
+1.82%-2.12%-28.64%-56.08% 5.25Cr
-2.23%-2.09%+17.75%+73.26% 5.86TCr
+0.11%-.--%-.--%-.--% 1.3TCr
+0.43%+4.96%+32.55%+197.79% 1.15TCr
+5.17%+1.49%+21.42%+81.72% 824.03Cr
-0.17%+1.56%-3.93%+0.34% 757.65Cr
-0.17%+7.01%+62.90%+73.75% 611.3Cr
-0.26%-3.66%-20.12%+53.90% 542.77Cr
-0.03%+2.40%-16.38%-5.89% 514.27Cr
-1.70%-0.30%-34.74%-34.53% 390.12Cr
Average +0.30%+1.14%+3.08%+38.43% 1.19TCr
Weighted average by Cap. -0.77%+0.30%+13.51%+65.37%

Financials

2025 2026
Net sales 309.55Cr 3.27Cr 2.81Cr 2.64Cr 2.41Cr 4.5Cr 4.52Cr 31Cr 12Cr 158.22Cr 12Cr 12Cr 503.49Cr 361.62Cr 3.81Cr 3.28Cr 3.09Cr 2.82Cr 5.25Cr 5.28Cr 37Cr 14Cr 184.84Cr 14Cr 14Cr 588.19Cr
Net income 17Cr 17.61L 15.14L 14.25L 13L 24.26L 24.39L 1.69Cr 65.3L 8.53Cr 66.13L 64.69L 27Cr 12Cr 13.08L 11.25L 10.58L 10L 18.02L 18.11L 1.25Cr 48.5L 6.34Cr 49.12L 48.05L 20Cr
Net Debt 77Cr 80.96L 69.61L 65.49L 59.77L 1.12Cr 1.12Cr 7.76Cr 3Cr 39Cr 3.04Cr 2.97Cr 124.85Cr 88Cr 93.27L 80.19L 75.45L 68.85L 1.28Cr 1.29Cr 8.94Cr 3.46Cr 45Cr 3.5Cr 3.43Cr 143.82Cr
Logo Shivalik Rasayan Limited
Shivalik Rasayan Limited is an India-based company. The Company’s segments are engaged in agrochemicals, active pharma ingredients (API), and pharma formulation. It is the producer of Malathion Technical and Dimethoate Technical. Malathion Technical is a non-systemic, wide spectrum organophosphorus (OP) based contact insecticide. Dimethoate Technical is used in preparation of formulations used in the control of a range of insects and mites. It also manufactures organophosphorus-based insecticides and chemicals. It has a diverse product range and product mix in order to serve consumer requirements. The APIs are being developed and manufactured in the niche area of oncology, ARVs, cardiovascular, metabolic disorders and immunology. It offers solutions from product selection to development to commercialization for a range of oncology and non-oncology products. The Company’s oncology products include Azacitidine, Busulfan, Bortezomib, and various others.
Employees
342
Date Price Change Volume
08/26/08 ₹320.95 +1.82% 10,873
07/26/07 ₹315.20 -3.98% 29,590
04/26/04 ₹328.25 +4.69% 10,152
03/26/03 ₹313.55 -3.61% 2,562
02/26/02 ₹325.30 -4.27% 6,431
  1. Stock Market
  2. Stocks
  3. SHIVALIK Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!